Logo
x

Search

Subscribe Now

Designation

Bone Health's OsteoBoost Vibration Belt Receives the US FDA's Breakthrough Device Designation for Osteoporosis

Bone Health's OsteoBoost Vibration Belt Receives the US FDA's Breakthrough Device Designation for Osteoporosis

  • December 16, 2020
Novartis' Iptacopan (LNP023) Receives the US FDA's Breakthrough Therapy Designation for PNH and Rare Pediatric Disease Designation for C3G

Novartis' Iptacopan (LNP023) Receives the US FDA's Breakthrough Therapy Designation for PNH and Rare Pediatric Disease Designation...

  • December 16, 2020
Novartis's Branaplam (LMI070) Receives the US FDA's Orphan Drug Designation for Huntington's Disease

Novartis's Branaplam (LMI070) Receives the US FDA's Orphan Drug Designation for Huntington's Disease

  • October 22, 2020
Prestige's PBP1510 Receives EMA's Positive Opinion on Orphan Designation for Pancreatic Cancer

Prestige's PBP1510 Receives EMA's Positive Opinion on Orphan Designation for Pancreatic Cancer

  • October 14, 2020
Novartis's Iptacopan (LNP023) Receives EMA's Prime Designation for C3 Glomerulopathy

Novartis's Iptacopan (LNP023) Receives EMA's Prime Designation for C3 Glomerulopathy

  • October 12, 2020
Dermira‘s Lebrikizumab Receives the US FDA's Fast Track Designation to Treat Atopic Dermatitis

Dermira‘s Lebrikizumab Receives the US FDA's Fast Track Designation to Treat Atopic Dermatitis

  • December 11, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.